Brief: Pherecydes Pharma: 1st Registration Of Phagogram As In Vitro Diagnostic Test
12/09/2022 16:51
Sept 12 (Reuters) - Pherecydes Pharma SA ALPHE.PA :
* PHERECYDES PHARMA ANNOUNCES A FIRST REGISTRATION OF ITS
PHAGOGRAM AS AN IN VITRO DIAGNOSTIC TEST IN ACCORDANCE WITH EC
DIRECTIVES
* THIS VITAL TOOL FOR PRECISION MEDICINE THUS MEETS
REGULATORY
REQUIREMENTS AND CLINICIANS' EXPECTATIONS
Source text for Eikon: ID:nBw7C0PlSa
Further company coverage: ALPHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pherecydes Pharma SA
See all newsBrief: Erytech And Pherecydes Announce Merger And Name Change To Phaxiam Therapeutics
Brief: Pherecydes Pharma SA - Pherecydes Pharma And Erytech Pharma Shareholders Approve Merger Between Two Companies To Create Phaxiam Therapeutics
Brief: Erytech Announces That The Commercial Court Has Rejected Akkadian's Request To Postpone The Vote On The Merger With Pherecydes Pharma
Brief: Erytech: urges shareholders to vote for merger with Pherecydes and dismisses Akkadian's moves
Brief: Erytech Pharma Says Akkadian Has Initiated Proceedings To Postpone Vote On Merger With Pherecydes